NMD4C Announces 2023 Early Career Award Recipients
We are excited to announce the recipients of the inaugural NMD4C Early Career Awards for 2023! This annual award program introduces three new awards, celebrating excellence and contribution to the neuromuscular field by early career investigators across both clinical and basic science streams.
This year, the NMD4C awarded three Early Career Awards as a part of this program: Early Career Biomedical Researcher of the Year, Early Career Clinical Researcher of the Year, and Early Career Publication of the Year.
We would like to congratulate this year’s recipients:
Early Career Biomedical Researcher of the Year award:
Dr. Nicolas Dumont, Associate professor, Rehabilitation department, University of Montreal
Early Career Clinical Researcher of the Year award:
Dr. Cam-Tu Émilie Nguyen, Neurologist, Assistant Professor, CHU Sainte-Justine, Université de Montréal
Early Career Publication of the Year:
Dr. Farshad Babaeijandaghi, Postdoctoral Fellow, Fabio Rossi Lab, University of British Columbia
“Metabolic reprogramming of skeletal muscle by resident macrophages points to CSF1R inhibitors as muscular dystrophy therapeutics”.
By creating these awards, the NMD4C provides a method of recognizing outstanding achievement by early career neuromuscular researchers and clinicians on behalf of the Canadian neuromuscular community. Recipients receive a tangible accolade to bolster their academic CVs in pursuit of future academic appointments and grant applications. This award program is a part of the network’s broader strategy to provide support for Canadian early-career neuromuscular investigators.
“Early career investigators are at a stage in their careers where finding the funding and academic appointments to continue their research programs and clinical work is integral to their career progression in the field of neuromuscular care and research. These applications are highly competitive, and it is our hope that receiving an NMD4C award can help support and strengthen these applications to secure important research funding and academic appointments.”
- Dr. Natasha Chang, Assistant Professor, Department of Biochemistry, McGill University and NMD4C Early-Career working group member
Thank you to all those who submitted nominations for these awards; we received many strong applications, and we look forward to hosting these awards again for the coming year. More information on the application process for 2024 is available on our awards page.
Read next...
NMD4C Launch Canadian Neuromuscular Clinical Trial Network
We are thrilled to announce the launch of a Canadian neuromuscular clinical trial network (CTN) as a part of our clinical research work.
Training Session for Physiotherapists and Occupational Therapists on Outcome Measures in Spinal muscular atrophy hosted by Quebec SMA Network
This past March 23, the Quebec SMA Network (Réseau québécois de l’amyotrophie spinale – RQAS) in collaboration with the NMD4C and Muscular Dystrophy Canada (MDC) hosted an interactive training session for French-speaking physiotherapists and occupational therapists on assessment measures and practices for Spinal muscular atrophy (SMA). This training gathered clinicians to train and discuss SMA standardized outcome measures and work through current problems/challenges, to improve how these measures often tied to drug reimbursement are conducted.
MDC Announce Recipients of 2024 Neuromuscular Clinical and Translational Research Grants
Muscular Dystrophy Canada (MDC) recently announced the recipients of its annual Neuromuscular Research Grants competition. Through these grants, MDC is investing $900,000 into clinical and translational research projects.
SMA Outcome Measures Training for Physiotherapists and Occupational Therapists
To support the development and training on validated NMD outcome measures we are pleased to provide opportunities for physiotherapists and occupational therapists to attend training sessions for outcome measures.
Congratulations to the 2024 NMD4C Early Career Awards Recipients
We are excited to announce the recipients of the 2024 NMD4C Early Career Awards! This is the second year of our annual award program, celebrating excellence and contribution to the neuromuscular field from early career investigators across both clinical and basic science streams.
MICYRN Secures $20 Million Grant from CIHR for a Pediatric Rare Disease Clinical Trials and Treatment Network
The NMD4C are excited to share that MICYRN’s success in securing a $20 million grant from CIHR Institute of Genetics to support the development and execution of RareKids-CAN: Pediatric Rare Disease Clinical Trials and Treatment Network.